# EDGAR Filing Document

**Accession Number:** 0000026058
**File Stem:** 0000950170-25-098145
**Filing Date:** 2025-7
**Character Count:** 66604
**Document Hash:** 85745d4dedf406f4cc439c44ad05fc9a
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000950170-25-098145.hdr.sgml**: 20250724

**ACCESSION NUMBER**: 0000950170-25-098145

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 32

**CONFORMED PERIOD OF REPORT**: 20250724

**ITEM INFORMATION**: Results of Operations and Financial Condition

**ITEM INFORMATION**: Regulation FD Disclosure

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20250724

**DATE AS OF CHANGE**: 20250724

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** CTS CORP
- **CENTRAL INDEX KEY:** 0000026058
- **STANDARD INDUSTRIAL CLASSIFICATION:** PRINTED CIRCUIT BOARDS [3672]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 350225010
- **STATE OF INCORPORATION:** IN
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-04639
- **FILM NUMBER:** 251144555

**BUSINESS ADDRESS:**
- **STREET 1:** 4925 INDIANA AVENUE
- **CITY:** LISLE
- **STATE:** IL
- **ZIP:** 60532
- **BUSINESS PHONE:** 6305778800

**MAIL ADDRESS:**
- **STREET 1:** 4925 INDIANA AVENUE
- **CITY:** LISLE
- **STATE:** IL
- **ZIP:** 60532

?xml version='1.0' encoding='ASCII'? 8-K

**UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549**

------

## **FORM** 8-K

------

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934**

**Date of Report (Date of earliest event reported):** July 24, 2025<br>

------

CTS CORPORATION

**(Exact name of Registrant as Specified in Its Charter)**

------

---

| | | |
|:---|:---|:---|
| Indiana | 1-4639 | 35-0225010 |
| **(State or Other Jurisdiction<br>of Incorporation)** | **(Commission File Number)** | **(IRS Employer<br>Identification No.)** |
| 4925 Indiana Avenue |  |  |
| Lisle**,** Illinois |  | 60532 |
| **(Address of Principal Executive Offices)** |  | **(Zip Code)** |

---

**Registrant's Telephone Number, Including Area Code:** (630) 577-8800<br>

**(Former Name or Former Address, if Changed Since Last Report)**

------

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

**Securities registered pursuant to Section 12(b) of the Act:**

---

| | | |
|:---|:---|:---|
| **<br>Title of each class** | **Trading<br>Symbol(s)** | **<br>Name of each exchange on which registered** |
| Common Stock, no par value | CTS | The New York Stock Exchange |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

**Item 2.02 Results of Operations and Financial Condition.**

On July 24, 2025, CTS Corporation (the "Company") issued a press release providing certain results for the second quarter ended June 30, 2025, as more fully described in the press release. A copy of the press release is attached hereto as Exhibit 99.l and is incorporated by reference herein.

The information contained in Item 2.02 of this Current Report on Form 8-K, including Exhibit 99.l hereto, is being "furnished" to the Securities and Exchange Commission and shall not be deemed to be "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section. Furthermore, such information shall not be deemed to be incorporated by reference into any filing made by the Company under the Securities Act of 1933 (the "Securities Act") or the Exchange Act, except as set forth by specific reference in such filing.

**Item 7.01 Regulation FD Disclosure.**

As disclosed in the press release furnished as Exhibit 99.1, the Company will hold a live web cast on July 24, 2025, relating to the Company's financial results for the second quarter ended June 30, 2025. A copy of the slides to be presented during the Company's web cast and discussed in the conference call relating to such financial results is being furnished as Exhibit 99.2 to this Current Report on Form 8-K.

By filing this Current Report on Form 8-K and furnishing the information contained herein, the Company makes no admission as to the materiality of any information in this report that is required to be disclosed solely by reason of Regulation FD.

The information contained in Item 7.01 of this Current Report on Form 8-K and Exhibit 99.2 shall not be deemed to be "filed" for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section. Furthermore, such information shall not be deemed to be incorporated by reference into any filing made by the Company under the Securities Act or the Exchange Act, except as set forth by specific reference in such filing.

**Item 9.01. Financial Statements and Exhibits.**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Exhibits

---

| | |
|:---|:---|
| **Exhibit** | **Description** |
| 99.1 | [<u>Earnings Release dated July 24, 2025</u>](cts-ex99_1.htm) |
| 99.2 | [<u>Slides of CTS Corporation, 2nd Quarter 2025, dated July 24, 2025</u>](cts-ex99_2.htm) |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL Document) |

---

------

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
| Date: July 24, 2025 |  | **CTS CORPORATION** |
|  | By: | */s/ Ashish Agrawal* |
|  |  | Ashish Agrawal |
|  |  | Vice President and Chief Financial Officer<br>|

---

------

## Exhibit 99.1

Exhibit 99.1

![img192797187_0.jpg](img192797187_0.jpg)

July 24, 2025 FOR IMMEDIATE RELEASE

**CTS Announces Second Quarter 2025 Results**

***Advancing Diversification and Profitability***

**Lisle, Ill. -** CTS Corporation (NYSE: CTS), a leading global designer and manufacturer of custom engineered solutions that "Sense, Connect and Move," today announced second quarter 2025 results.

"We delivered another quarter of double-digit sales growth in the diversified end markets and achieved solid profitability with adjusted EBITDA margin expanding 130 basis points. We also generated strong operating cash flow in the quarter," said Kieran O'Sullivan, CEO of CTS Corporation. "Our teams remain focused on diversification as a strategic priority through organic growth and acquisitions."

**Second Quarter 2025 Results** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Sales were $135 million in the second quarter of 2025, up 4% year-over-year. Sales to diversified end markets increased 13%. Sales to the transportation end market decreased 6%.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Net income was $19 million, or 14% of sales, up from $15 million, or 11% of sales, in the second quarter of 2024.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Diluted EPS was $0.62, up from $0.48 in the second quarter of 2024.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Adjusted diluted EPS was $0.57, up from $0.54 in the second quarter of 2024.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Adjusted EBITDA margin was 23.0%, up from 21.7% in the second quarter of 2024.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Operating cash flow was $28 million, compared to $20 million in the second quarter of 2024.

**2025 Guidance**

Assuming the continuation of current market conditions, CTS is maintaining its guidance of sales in the range of $520-$550 million and adjusted diluted EPS to be in the range of $2.20-$2.35.

CTS does not provide reconciliations of forward-looking non-GAAP financial measures, such as estimated adjusted diluted earnings per share, to the most comparable GAAP financial measures on a forward-looking basis because CTS is unable to provide a meaningful or accurate calculation or estimation of reconciling items and the information is not available without unreasonable effort. This is due to the inherent difficulty of forecasting the timing and amount of certain items, such as, but not limited to, restructuring costs, environmental remediation costs, acquisition-related costs, foreign exchange rates and other non-routine costs. Each of such adjustments has not yet occurred, are out of CTS' control and/or cannot be reasonably predicted. For the same reasons, CTS is unable to address the probable significance of the unavailable information.

www.ctscorp.com

------

**Conference Call and Supplemental Materials**

As previously announced, CTS has scheduled a conference call for 10:00 a.m. (ET) today. The dial-in numbers for access from the U.S. are: +1-833-470-1428 (Toll-Free) and +1-404-975-4839 (Local), if calling from outside the U.S., please refer to <u>Global Dial In Numbers</u> to identify the applicable dial-in number for your location. The passcode is 932754. In addition, CTS will be using a supplemental slide presentation that will be referred to during the call. The presentation and a live audio webcast of the conference call will be available and can be accessed directly from CTS' website at <u>https://investors.ctscorp.com/news-events/events-and-presentations/.</u>

Any replay, rebroadcast, transcript or other reproduction or transmission of this conference call, other than the replay accessible through the website noted above, has not been authorized by CTS and is strictly prohibited. Investors should be aware that any unauthorized reproduction of this conference call may not be an accurate reflection of its contents.

**About CTS** 

CTS Corporation (NYSE: CTS) is a leading designer and manufacturer of products that Sense, Connect and Move. CTS manufactures sensors, actuators and electronic components in North America, Europe and Asia, and provides engineered products to customers in the aerospace & defense, industrial, medical and transportation markets. For more information, visit <u>www.ctscorp.com/</u>.

Diversified end markets, previously referred as the "non-transportation" market, includes the industrial, aerospace & defense, and medical end markets.

www.ctscorp.com

------

**Cautionary Statement Regarding Forward-Looking Statements** 

Readers are cautioned that the statements contained in this document regarding expectations of our performance or other matters that may affect our business, results of operations, or financial condition are, or may be deemed to be, "forward-looking statements" as defined by the "safe harbor" provisions in the Private Securities Litigation Reform Act of 1995. Such statements are made in reliance on the safe harbor provisions of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements, other than statements of historical fact, included or incorporated in this document, including statements regarding our strategy, financial position, guidance, funding for continued operations, cash reserves, liquidity, projected costs, plans, projects, awards and contracts, and objectives of management, among others, are forward-looking statements. Words such as "expect," "anticipate," "should," "believe," "hope," "target," "continued," "project," "plan," "goals," "opportunity," "appeal," "estimate," "potential," "predict," "demonstrates," "may," "will," "might," "could," "intend," "shall," "possible," "would," "approximately," "likely," "outlook," "schedule," "on track," "poised," "pipeline," and variations of these terms or the negative of these terms and similar expressions are intended to identify these forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. These forward-looking statements are not guarantees of future performance, conditions or results. Forward-looking statements are based on management's expectations, certain assumptions, and currently available information. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof and are based on various assumptions as to future events, the occurrence of which necessarily are subject to uncertainties. These forward-looking statements are made subject to certain risks, uncertainties, and other factors, which could cause CTS' actual results, performance, or achievements to differ materially from those presented in the forward-looking statements. Examples of factors that may affect future operating results and financial condition include, but are not limited to: supply chain disruptions; changes in the economy generally, including inflationary and/or recessionary conditions and increased tariffs, and in respect to the business in which CTS operates; unanticipated issues in integrating acquisitions including, without limitation the integration of SyQwest; the funding of contracts by the US Government; the results of actions to reposition CTS' business; rapid technological change; general market conditions in the transportation, as well as conditions in the industrial, aerospace and defense, and medical markets; reliance on key customers; unanticipated public health crises, natural disasters or other events; environmental compliance and remediation expenses; the ability to protect CTS' intellectual property; pricing pressures and demand for CTS' products; risks associated with CTS' international operations, including trade and tariff barriers, exchange rates and political and geopolitical risks (including, without limitation, the impact of tariffs on China, Canada and Mexico, and other nations, the potential impact of U.S./China relations and the impact of the conflicts in Ukraine, and the Middle East may have on our business, results of operations and financial condition); the amount and timing of any share repurchases; and the effect of any cybersecurity incidents on our business. Many of these, and other risks and uncertainties, are discussed in further detail in Item 1A. of CTS' most recent Annual Report on Form 10-K and other filings made with the SEC. CTS undertakes no obligation to publicly update CTS' forward-looking statements to reflect new information or events or circumstances that arise after the date hereof, including market or industry changes.

**Contact** 

Ashish Agrawal

Vice President and Chief Financial Officer

CTS Corporation

4925 Indiana Avenue

Lisle, IL 60532 USA

+1 (630) 577-8800

<u>ashish.agrawal@ctscorp.com</u> 

www.ctscorp.com

------

**CTS CORPORATION AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED STATEMENTS OF EARNINGS - UNAUDITED**

*(In thousands, except per share amounts)*

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
|  | **June 30,<br>2025** | **June 30, <br>2024** | **June 30,<br>2025** | **June 30, <br>2024** |
| **Net sales** | $135309 | $130162 | $261078 | $255912 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cost of goods sold | 82878 | 83790 | 162099 | 164450 |
| Gross margin | 52431 | 46372 | 98979 | 91462 |
| &nbsp;&nbsp;&nbsp;&nbsp;Selling, general and administrative expenses | 23077 | 21332 | 46700 | 43591 |
| &nbsp;&nbsp;&nbsp;&nbsp;Research and development expenses | 6326 | 6086 | 12515 | 12687 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring charges | 297 | 1190 | 749 | 2884 |
| Operating earnings | 22731 | 17764 | 39015 | 32300 |
| Other (expense) income: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest expense | (1121) | (833) | (2289) | (1635) |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest income | 622 | 1441 | 1068 | 2827 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other income (expense), net | 750 | (603) | 1307 | (2066) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total other (expense) income, net | 251 | 5 | 86 | (874) |
| &nbsp;&nbsp;&nbsp;&nbsp;Earnings before income taxes | 22982 | 17769 | 39101 | 31426 |
| Income tax expense | 4455 | 3062 | 7210 | 5600 |
| **Net earnings** | $**18527** | $**14707** | $**31891** | $**25826** |
| **Earnings per share:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Basic | $0.62 | $0.48 | $1.07 | $0.84 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Diluted | $0.62 | $0.48 | $1.06 | $0.84 |
| **Basic weighted – average common shares outstanding:** | **29739** | **30511** | **29875** | **30627** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Effect of dilutive securities | 251 | 219 | 285 | 224 |
| **Diluted weighted – average common shares outstanding:** | **29990** | **30730** | **30160** | **30851** |
| **Cash dividends declared per share** | $0.04 | $0.04 | $0.08 | $0.08 |

---

www.ctscorp.com

------

**CTS CORPORATION AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED BALANCE SHEETS**

*(In thousands of dollars)*

---

| | | |
|:---|:---|:---|
|  | **(Unaudited)<br>June 30,<br> 2025** | **December 31, 2024** |
| **ASSETS** |  |  |
| Current Assets |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | $99440 | $94334 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable, net | 85578 | 77649 |
| &nbsp;&nbsp;&nbsp;&nbsp;Inventories, net | 57103 | 52312 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other current assets | 19629 | 17879 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current assets | 261750 | 242174 |
| Property, plant and equipment, net | 93530 | 94357 |
| Operating lease assets, net | 21709 | 22939 |
| Other Assets |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Goodwill | 207547 | 201304 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other intangible assets, net | 161785 | 163882 |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred income taxes | 26714 | 27591 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other | 11694 | 13180 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total other assets | 407740 | 405957 |
| **Total Assets** | $**784729** | $**765427** |
| **LIABILITIES AND SHAREHOLDERS' EQUITY** |  |  |
| Current Liabilities |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | $47265 | $42629 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued payroll and benefits | 4557 | 4719 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating lease obligations | 17444 | 15754 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued expenses and other liabilities | 31200 | 35361 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current liabilities | 100466 | 98463 |
| &nbsp;&nbsp;&nbsp;&nbsp;Long-term debt | 88000 | 92300 |
| &nbsp;&nbsp;&nbsp;&nbsp;Long-term operating lease obligations | 19999 | 21120 |
| &nbsp;&nbsp;&nbsp;&nbsp;Long-term pension obligations | 3872 | 3931 |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred income taxes | 14233 | 12743 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other long-term obligations | 8002 | 8662 |
| **Total Liabilities** | **234572** | **237219** |
| **Commitments and Contingencies** |  |  |
| Shareholders' Equity |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Common stock | 324682 | 321979 |
| &nbsp;&nbsp;&nbsp;&nbsp;Additional contributed capital | 41236 | 44662 |
| &nbsp;&nbsp;&nbsp;&nbsp;Retained earnings | 682360 | 652851 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accumulated other comprehensive loss | 12020 | (4266) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total shareholders' equity before treasury stock | 1060298 | 1015226 |
| &nbsp;&nbsp;&nbsp;&nbsp;Treasury stock | (510141) | (487018) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total shareholders' equity | 550157 | 528208 |
| **Total Liabilities and Shareholders' Equity** | $**784729** | $**765427** |

---

www.ctscorp.com

------

**CTS CORPORATION AND SUBSIDIARIES**

**OTHER SUPPLEMENTAL INFORMATION - UNAUDITED**

*(In millions of dollars, except percentages and per share amounts)*

**Non-GAAP Financial Measures** 

From time to time, CTS may use non-GAAP financial measures in discussing CTS' business. These measures are intended to supplement, not replace, CTS' presentation of its financial results in accordance with U.S. GAAP. CTS believes that the non-GAAP financial measures presented are commonly used by financial analysts and others in the industries in which CTS operates, and thus further provide useful information to investors. CTS' definitions of these non-GAAP financial measures may differ from those terms as defined or used by other companies. Non-GAAP measures should not be used by investors or third parties as the sole basis for formulating investment decisions, as they may exclude a number of important cash and non-cash recurring items.

CTS has presented these non-GAAP financial measures as it believes that the presentation of its financial results that exclude (1) restructuring charges; (2) restructuring-related charges; (3) environmental charges; (4) acquisition-related adjustments; (5) inventory fair value step-up costs; (6) foreign exchange (gains) losses; (7) non-cash pension expenses (income); and (8) certain discrete tax items are useful and assist in comparing CTS' current operating results with past periods and with the operational performance of other companies in its industry. Included below is a description of the expenses that CTS has determined are not normal, recurring cash operating expenses necessary to operate its business and the rationale for why providing financial measures for its business with such expenses excluded or adjusted is useful to investors as a supplement to the U.S. GAAP measures.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•<u>Restructuring charges</u> – costs primarily relating to workforce reduction costs, building and equipment relocation costs, asset impairment charges and other facility closure costs in connection with our continued optimization of our organization.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•<u>Restructuring-related charges</u> – costs related to restructuring actions that do not qualify as direct restructuring charges under US GAAP. These include duplicative expenses incurred due to the plant consolidation related transition activities such as excess rent, utilities, personnel related and other costs prior to start of production at the new location.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•<u>Environmental charges</u> – costs associated with our non-operating facilities that are unrelated to ongoing operations. Currently, none of these costs and accruals relate to sites that provide revenue generating activities for the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•<u>Acquisition-related adjustments</u> – diligence and transaction costs related to acquisitions including related contingent earnout adjustments.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•<u>Inventory fair value step-up costs</u> – purchase accounting-related inventory costs from acquisitions.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•<u>Foreign exchange (gains) losses</u> – remeasurement income and expenses for non-U.S. subsidiaries with the U.S. dollar as the functional currency.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•<u>Non-cash pension expenses (income)</u> – pension income and expenses relating to the non-operating U.S. pension and post-retirement life insurance plans, including historical plan settlement activities.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•<u>Discrete tax items</u> – non-recurring, infrequent, or unusual tax adjustments (e.g., valuation allowances, uncertain tax position changes, unremitted assertion changes and discrete impacts associated with pre-tax non-GAAP items or due to tax law changes, etc.).

At times, the reconciliations below have been intentionally rounded to the nearest thousand, or $0.01 for EPS figures, and, therefore, may not sum.

www.ctscorp.com

------

**<u>Adjusted Gross Margin</u>**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Three Months Ended<br>June 30,** | **Three Months Ended<br>June 30,** | **Six Months Ended<br>June 30,** | **Six Months Ended<br>June 30,** | **Twelve Months Ended<br>December 31,** | **Twelve Months Ended<br>December 31,** | **Twelve Months Ended<br>December 31,** |
|  | **2025** | **2024** | **2025** | **2024** | **2024** | **2023** | **2022** |
| **Gross margin** | $**52.4** | $**46.4** | $**99.0** | $**91.5** | $**187.6** | $**190.9** | $**210.5** |
| Net sales | $135.3 | $130.2 | $261.1 | $255.9 | $514.8 | $550.4 | $586.9 |
| **Gross margin as a % of net sales** | **38.7%** | **35.6%** | **37.9%** | **35.7%** | **36.4%** | **34.7%** | **35.9%** |
| Adjustments to reported gross margin: |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring-related charges (b) |  | 0.2 |  | 0.7 | 0.7 | 0.6 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Inventory fair value step-up (b) |  |  |  |  | 2.1 |  | 4.0 |
| **Adjusted gross margin** | $52.4 | $46.6 | $99.0 | $92.2 | $190.4 | $191.5 | $214.5 |
| **Adjusted gross margin as a % of net sales** | **38.7%** | **35.8%** | **37.9%** | **36.0%** | **37.0%** | **34.8%** | **36.5%** |

---

------

**<u>Adjusted Operating Earnings</u>**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Three Months Ended<br>June 30,** | **Three Months Ended<br>June 30,** | **Six Months Ended<br>June 30,** | **Six Months Ended<br>June 30,** | **Twelve Months Ended<br>December 31,** | **Twelve Months Ended<br>December 31,** | **Twelve Months Ended<br>December 31,** |
|  | **2025** | **2024** | **2025** | **2024** | **2024** | **2023** | **2022** |
| **Operating earnings** | $22.7 | $17.8 | $39.0 | $32.3 | $71.2 | $75.1 | $93.0 |
| Net sales | $135.3 | $130.2 | $261.1 | $255.9 | $514.8 | $550.4 | $586.9 |
| **Operating earnings as a % of net sales** | **16.8%** | **13.6%** | **14.9%** | **12.6%** | **13.8%** | **13.6%** | **15.8%** |
| Adjustments to reported operating earnings: |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring charges (c) | 0.3 | 1.2 | 0.7 | 2.9 | 4.7 | 7.1 | 1.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring-related charges (b) |  | 0.2 |  | 0.7 | 0.7 | 0.6 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Environmental charges (a) | 0.2 | 0.5 | 0.4 | 0.7 | 1.6 | 3.5 | 2.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;Acquisition-related adjustments (a) | (1.3) | (0.3) | (1.5) | (0.6) | (0.3) | 0.4 | 0.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;Inventory fair value step-up (b) |  |  |  |  | 2.1 |  | 4.0 |
| Total adjustments to reported operating earnings | $(0.8) | $1.6 | $(0.4) | $3.8 | $8.8 | $11.5 | $9.5 |
| **Adjusted operating earnings** | $21.9 | $19.4 | $38.6 | $36.1 | $80.0 | $86.6 | $102.5 |
| **Adjusted operating earnings as a % of net sales** | **16.2%** | **14.9%** | **14.8%** | **14.1%** | **15.5%** | **15.7%** | **17.5%** |

---

------

**<u>Adjusted EBITDA Margin</u>**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Three Months Ended<br>June 30,** | **Three Months Ended<br>June 30,** | **Six Months Ended<br>June 30,** | **Six Months Ended<br>June 30,** | **Twelve Months Ended<br>December 31,** | **Twelve Months Ended<br>December 31,** | **Twelve Months Ended<br>December 31,** |
|  | **2025** | **2024** | **2025** | **2024** | **2024** | **2023** | **2022** |
| Net earnings | $18.5 | $14.7 | $31.9 | $25.8 | $55.5 | $60.5 | $59.6 |
| Net sales | $135.3 | $130.2 | $261.1 | $255.9 | $514.8 | $550.4 | $586.9 |
| **Net earnings margin** | **13.7%** | **11.3%** | **12.2%** | **10.1%** | **10.8%** | **11.0%** | **10.2%** |
| Depreciation and amortization expense | 8.6 | 7.3 | 17.0 | 14.7 | 30.9 | 28.7 | 29.8 |
| Interest expense | 1.1 | 0.8 | 2.3 | 1.6 | 4.2 | 3.3 | 2.2 |
| Tax expense | 4.5 | 3.1 | 7.2 | 5.6 | 13.1 | 14.6 | 21.2 |
| **EBITDA** | 32.7 | 25.9 | 58.4 | 47.7 | 103.7 | 107.2 | 112.7 |
| **EBITDA Margin** | **24.2%** | **19.9%** | **22.4%** | **18.6%** | **20.1%** | **19.5%** | **19.2%** |
| Adjustments to EBITDA: |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Restructuring charges (c) | 0.3 | 1.2 | 0.7 | 2.9 | 4.7 | 7.1 | 1.9 |
| &nbsp;&nbsp;&nbsp;&nbsp; Restructuring-related charges (b) |  | 0.2 |  | 0.7 | 0.7 | 0.6 |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Environmental charges (a) | 0.2 | 0.5 | 0.4 | 0.7 | 1.6 | 3.5 | 2.8 |
| &nbsp;&nbsp;&nbsp;&nbsp; Acquisition-related adjustments (a) | (1.3) | (0.3) | (1.5) | (0.6) | (0.3) | 0.4 | 2.5 |
| &nbsp;&nbsp;&nbsp;&nbsp; Inventory fair value step-up (b) |  |  |  |  | 2.1 |  | 4.0 |
| &nbsp;&nbsp;&nbsp;&nbsp; Non-cash pension and related expense (d) |  | 0.1 | 0.1 | 0.1 | 0.2 |  | 4.8 |
| &nbsp;&nbsp;&nbsp;&nbsp; Foreign currency (gain) loss (d) | (0.8) | 0.6 | (1.3) | 2.1 | 2.7 | 2.0 | 4.9 |
| Total adjustments to EBITDA | (1.6) | 2.3 | (1.6) | 6.0 | 11.7 | 13.5 | 20.9 |
| **Adjusted EBITDA** | $31.1 | $28.2 | $56.8 | $53.7 | $115.4 | $120.7 | $133.6 |
| **Adjusted EBITDA Margin** | **23.0%** | **21.7%** | **21.8%** | **21.0%** | **22.4%** | **21.9%** | **22.8%** |

---

------

**<u>Adjusted Net Earnings and Adjusted Diluted Earnings Per Share</u>**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Three Months Ended<br>June 30,** | **Three Months Ended<br>June 30,** | **Three Months Ended<br>June 30,** | **Three Months Ended<br>June 30,** | **Six Months Ended<br>June 30,** | **Six Months Ended<br>June 30,** | **Six Months Ended<br>June 30,** | **Six Months Ended<br>June 30,** |
|  | **2025** | **2025** | **2024** | **2024** | **2025** | **2025** | **2024** | **2024** |
|  |  | Per share |  | Per share |  | Per share |  | Per share |
| **Net earnings (A)** | $18.5 | $0.62 | $14.7 | $0.48 | $31.9 | $1.06 | $25.8 | $0.84 |
| Adjustments to reported net earnings: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring charges (c) | 0.3 | 0.01 | 1.2 | 0.04 | 0.7 | 0.03 | 2.9 | 0.09 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring-related charges (a) |  |  | 0.2 | 0.01 |  |  | 0.7 | 0.02 |
| &nbsp;&nbsp;&nbsp;&nbsp;Environmental charges (a) | 0.2 | 0.01 | 0.5 | 0.02 | 0.4 | 0.01 | 0.7 | 0.02 |
| &nbsp;&nbsp;&nbsp;&nbsp;Acquisition-related adjustments (a) | (1.3) | (0.05) | (0.3) | (0.01) | (1.5) | (0.05) | (0.6) | (0.02) |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-cash pension and related expense (d) |  |  | 0.1 |  | 0.1 |  | 0.1 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign currency (gain) loss (d) | (0.8) | (0.03) | 0.6 | 0.02 | (1.3) | (0.04) | 2.1 | 0.07 |
| Total pretax adjustments to reported net earnings | $(1.6) | $(0.06) | $2.3 | $0.07 | $(1.6) | $(0.05) | $6.0 | $0.19 |
| &nbsp;&nbsp;&nbsp;&nbsp;Income tax effect of above adjustments (f) | 0.3 | 0.01 | (0.5) | (0.02) | 0.1 |  | (1.0) | (0.03) |
| Total adjustments, tax affected (f) **(B)** | $(1.3) | $(0.05) | $1.8 | $0.06 | $(1.5) | $(0.05) | $5.0 | $0.16 |
| Tax adjustments: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Other discrete tax items (e) | 0.1 |  |  |  | 0.1 |  | 0.3 | 0.01 |
| Total tax adjustments **(C)** | $0.1 | $— | $— | $— | $0.1 | $— | $0.3 | $0.01 |
| **Adjusted net earnings (A+B+C) and Adjusted net earnings per share** | $17.3 | $0.57 | $16.5 | $0.54 | $30.5 | $1.01 | $31.1 | $1.01 |
| Net sales | $135.3 |  | $130.2 |  | $261.1 |  | $255.9 |  |
| **Net earnings as a % of net sales** | **13.7%** |  | **11.3%** |  | **12.2%** |  | **10.1%** |  |
| **Adjusted net earnings as a % of net sales** | **12.8%** |  | **12.7%** |  | **11.7%** |  | **12.1%** |  |

---

------

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Twelve Months Ended<br>December 31,** | **Twelve Months Ended<br>December 31,** | **Twelve Months Ended<br>December 31,** | **Twelve Months Ended<br>December 31,** | **Twelve Months Ended<br>December 31,** | **Twelve Months Ended<br>December 31,** |
|  | **2024** | **2024** | **2023** | **2023** | **2022** | **2022** |
|  |  | Per share |  | Per share |  | Per share |
| **Net earnings (A)** | $55.5 | $1.80 | $60.5 | $1.92 | $59.6 | $1.85 |
| Adjustments to reported net earnings: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring charges (c) | 4.7 | 0.15 | 7.1 | 0.22 | 1.9 | 0.06 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring-related charges (a) | 0.7 | 0.02 | 0.6 | 0.02 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Environmental charges (a) | 1.6 | 0.05 | 3.5 | 0.11 | 2.8 | 0.09 |
| &nbsp;&nbsp;&nbsp;&nbsp;Acquisition-related adjustments (a) | (0.3) | (0.01) | 0.4 | 0.01 | 2.5 | 0.08 |
| &nbsp;&nbsp;&nbsp;&nbsp;Inventory fair value step-up (b) | 2.1 | 0.07 |  |  | 4.0 | 0.12 |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-cash pension and related expense (d) | 0.2 | 0.01 |  |  | 4.8 | 0.15 |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign currency loss (d) | 2.7 | 0.09 | 2.0 | 0.06 | 4.9 | 0.15 |
| Total pretax adjustments to reported net earnings | $11.7 | $0.38 | $13.5 | $0.42 | $20.9 | $0.65 |
| &nbsp;&nbsp;&nbsp;&nbsp;Income tax effect of above adjustments (f) | (2.2) | (0.07) | (2.4) | (0.07) | (1.6) | (0.05) |
| Total adjustments, tax affected (f) **(B)** | $9.5 | $0.31 | $11.1 | $0.35 | $19.3 | $0.60 |
| Tax adjustments: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Increase in valuation allowances (e) |  |  |  |  |  | - |
| &nbsp;&nbsp;&nbsp;&nbsp;Other discrete tax items (e) | 0.3 | 0.01 | (1.6) | (0.05) | 0.2 | 0.01 |
| Total tax adjustments **(C)** | $0.3 | $0.01 | $(1.6) | $(0.05) | $0.2 | $0.01 |
| **Adjusted net earnings (A+B+C) and Adjusted net earnings per share** | $65.3 | $2.12 | $70.0 | $2.22 | $79.1 | $2.46 |
| Net sales | $514.8 |  | $550.4 |  | $586.9 |  |
| **Net earnings as a % of net sales** | **10.8%** |  | **11.0%** |  | **10.2%** |  |
| **Adjusted net earnings as a % of net sales** | **12.7%** |  | **12.7%** |  | **13.5%** |  |

---

(a) Reflected in selling, general and administrative and other (expense) income, net.<br>(b) Reflected in cost of goods sold.<br>(c) Reflected in restructuring charges.

(d) Reflected in other (expense) income, net.

------

(e) Reflected in income tax expense (income). For 2022, the discrete tax items relate to the net impact to tax expense of expired research and development credits, including the release of associated reserves. For 2023, discrete tax items include adjusting for tax benefits resulting from $0.6 million for research and development tax credits from prior years, $0.8 million in foreign tax credits related to prior years from a 2023 tax law change, as well as $0.2 million from the release of uncertain tax benefits. For 2024, the discrete tax items relate to items we deemed outside normal cash-generating operations including the addition of a valuation allowance for a foreign subsidiary. For 2025, the discrete tax items relate to items we deemed outside normal cash-generating operations including the addition of a valuation allowance for research and developmental credits and the tax impacts of an immaterial correction of a prior period error.

(f) We determine the tax effect of non-GAAP adjustments by considering the tax laws and statutory income tax rates applicable in the tax jurisdictions of the underlying non-GAAP adjustments. For all periods presented, we applied the statutory income tax rates to the taxable portion of all of our adjustments. Our acquisition costs and foreign currency gains and losses included in our non-GAAP adjustments were not deductible for income tax purposes; therefore, no statutory income tax rate was applied to such costs.

*NOTE: CTS believes that adjusted gross margin, adjusted operating earnings, adjusted EBITDA margin, adjusted net earnings and adjusted diluted earnings per share provide useful information to investors regarding its operational performance because they enhance an investor's overall understanding of CTS' core financial performance and facilitate comparisons to historical results of operations, by excluding items that are not related directly to the underlying performance of CTS' fundamental business operations (such as those items noted above in the paragraph titled "Non-GAAP Financial Measures") or were not part of CTS' business operations during a comparable period.* 

**<u>Controllable Working Capital</u>**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **June 30,** | **June 30,** | **December 31,** | **December 31,** | **December 31,** |
|  | **2025** | **2024** | **2024** | **2023** | **2022** |
| Net accounts receivable | $85.6 | $85.4 | $77.6 | $78.6 | $90.9 |
| Net inventory | $57.1 | $51.7 | $52.3 | $60.0 | $62.3 |
| Accounts payable | $(47.3) | $(40.9) | $(42.6) | $(43.5) | $(53.2) |
| Controllable working capital | $95.4 | $96.2 | $87.3 | $95.1 | $100.0 |
| Quarter sales | $135.3 | $130.2 | $126.4 | $124.7 | $142.3 |
| Multiplied by 4 | 4 | 4 | 4 | 4 | 4 |
| Annualized sales | $541.2 | $520.6 | $505.6 | $498.8 | $569.1 |
| **Controllable working capital as a % of annualized sales** | **17.6%** | **18.5%** | **17.3%** | **19.1%** | **17.6%** |

---

*NOTE: CTS believes the controllable working capital ratio is a useful measure because it provides an objective measure of the efficiency with which CTS manages its short-term capital needs.* 

------

**<u>Free Cash Flow</u>**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Three Months Ended<br>June 30,** | **Three Months Ended<br>June 30,** | **Six Months Ended<br>June 30,** | **Six Months Ended<br>June 30,** | **Twelve Months Ended<br>December 31,** | **Twelve Months Ended<br>December 31,** | **Twelve Months Ended<br>December 31,** |
|  | **2025** | **2024** | **2025** | **2024** | **2024** | **2023** | **2022** |
| Net cash provided by operating activities | $28.4 | $19.6 | $43.9 | $37.9 | $98.2 | $88.8 | $121.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;Capital expenditures | (3.3) | (4.6) | (7.7) | (8.7) | (18.6) | (14.7) | (14.3) |
| Free cash flow | $**25.1** | $**15.0** | $**36.2** | $**29.3** | $**79.6** | $**74.1** | $**106.9** |
| Operating cash flow as a percentage of net earnings | 153% | 133% | 138% | 147% | 177% | 147% | 203% |
| Free cash flow as a percentage of adjusted net earnings | 145% | 91% | 119% | 94% | 122% | 106% | 135% |

---

*NOTE: CTS believes that free cash flow is a useful measure because it demonstrates the company's ability to generate cash. Free cash flow is a non-GAAP measure and should be considered in addition to, but not as a substitute for, information contained in the company's condensed consolidated statement of cash flows as a measure of liquidity.*

**<u>Capital Expenditures</u>**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Three Months Ended<br>June 30,** | **Three Months Ended<br>June 30,** | **Six Months Ended<br>June 30,** | **Six Months Ended<br>June 30,** | **Twelve Months Ended<br>December 31,** | **Twelve Months Ended<br>December 31,** | **Twelve Months Ended<br>December 31,** |
|  | **2025** | **2024** | **2025** | **2024** | **2024** | **2023** | **2022** |
| Capital expenditures | $3.3 | $4.6 | $7.7 | $8.7 | $18.6 | $14.7 | $14.3 |
| Net sales | $135.3 | $130.2 | $261.1 | $255.9 | $514.8 | $550.4 | $586.9 |
| **Capex as % of net sales** | **2.4%** | **3.6%** | **2.9%** | **3.4%** | **3.6%** | **2.7%** | **2.4%** |

---

**<u>Additional Information</u>**

The following table includes other financial information not presented in the preceding financial statements.

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Three Months Ended<br>June 30,** | **Three Months Ended<br>June 30,** | **Six Months Ended<br>June 30,** | **Six Months Ended<br>June 30,** | **Twelve Months Ended<br>December 31,** | **Twelve Months Ended<br>December 31,** | **Twelve Months Ended<br>December 31,** |
|  | **2025** | **2024** | **2025** | **2024** | **2024** | **2023** | **2022** |
| Depreciation and amortization expense | $8.6 | $7.3 | $17.0 | $14.7 | $30.9 | $28.7 | $29.8 |
| Stock-based compensation expense | $0.6 | $1.3 | $2.3 | $2.5 | $5.7 | $5.2 | $7.7 |

---

*The Company updated certain previously furnished 2024 amounts due to immaterial errors identified. Refer to Note 1, "Basis of Presentation" in the Quarterly Report on Form 10-Q as of June 30, 2025 for more information.* 

------

## Exhibit 99.2

![Slide 1](cts-ex99_2s1.jpg)

CTS Corporation 2nd Quarter 2025 Earnings Call July 24, 2025

------

![Slide 2](cts-ex99_2s2.jpg)

Cautionary Statement Regarding Forward-Looking Statements Readers are cautioned that the statements contained in this document regarding expectations of our performance or other matters that may affect our business, results of operations, or financial condition are, or may be deemed to be, "forward-looking statements" as defined by the "safe harbor" provisions in the Private Securities Litigation Reform Act of 1995. Such statements are made in reliance on the safe harbor provisions of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements, other than statements of historical fact, included or incorporated in this document, including statements regarding our strategy, financial position, guidance, funding for continued operations, cash reserves, liquidity, projected costs, plans, projects, awards and contracts, and objectives of management, among others, are forward-looking statements. Words such as "expect," "anticipate," "should," "believe," "hope," "target," "continued," "project," "plan," "goals," "opportunity," "appeal," "estimate," "potential," "predict," "demonstrates," "may," "will," "might," "could," "intend," "shall," "possible," "would," "approximately," "likely," "outlook," "schedule," "on track," "poised," "pipeline," and variations of these terms or the negative of these terms and similar expressions are intended to identify these forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. These forward-looking statements are not guarantees of future performance, conditions or results. Forward-looking statements are based on management's expectations, certain assumptions, and currently available information. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof and are based on various assumptions as to future events, the occurrence of which necessarily are subject to uncertainties. These forward-looking statements are made subject to certain risks, uncertainties, and other factors, which could cause CTS' actual results, performance, or achievements to differ materially from those presented in the forward-looking statements. Examples of factors that may affect future operating results and financial condition include, but are not limited to: supply chain disruptions; changes in the economy generally, including inflationary and/or recessionary conditions and increased tariffs, and in respect to the business in which CTS operates; unanticipated issues in integrating acquisitions including, without limitation the integration of SyQwest; the funding of contracts by the US Government; the results of actions to reposition CTS' business; rapid technological change; general market conditions in the transportation, as well as conditions in the industrial, aerospace and defense, and medical markets; reliance on key customers; unanticipated public health crises, natural disasters or other events; environmental compliance and remediation expenses; the ability to protect CTS' intellectual property; pricing pressures and demand for CTS' products; risks associated with CTS' international operations, including trade and tariff barriers, exchange rates and political and geopolitical risks (including, without limitation, the impact of tariffs on China, Canada and Mexico, and other nations, the potential impact of U.S./China relations and the impact of the conflicts in Ukraine, and the Middle East may have on our business, results of operations and financial condition); the amount and timing of any share repurchases; and the effect of any cybersecurity incidents on our business. Many of these, and other risks and uncertainties, are discussed in further detail in Item 1A. of CTS' most recent Annual Report on Form 10-K and other filings made with the SEC. CTS undertakes no obligation to publicly update CTS' forward-looking statements to reflect new information or events or circumstances that arise after the date hereof, including market or industry changes. CTS refers to the forward-looking measures of book-to-bill ratio and total booked business in this document. Book-to-bill ratio is the ratio of customer orders received to revenues recorded for the same period. Although the book-to-bill ratio reflects firm customer orders, changes such as terminations, amendments, or contract cancellations may occur which could result in a reduction to the customer orders. Total booked business reflects expected revenue from the remaining life of long-term agreements with transportation customers. Total booked business is adjusted periodically for changes in expected revenue based on market information, fluctuations in foreign currency exchange rates, information from our customers, and any other factors that may impact the expected revenue from these agreements. Book-to-bill ratio and total booked business are not defined by U.S. GAAP and our methodology for calculating these measures may not be consistent with or comparable to other similarly titled measures of other companies.

------

![Slide 3](cts-ex99_2s3.jpg)

&nbsp;&nbsp;&nbsp;&nbsp;Solid growth from diversified end markets2 Revenue up 13% year-over-year 55% of total revenue Transportation end market remains challenging Revenue down (6)% year-over-year Lower commercial vehicle sales China softness Book-to-bill ratio3 1, added 2 new customers Generated $28M in operating cash flow Notes: All comparisons vs. same period in prior year unless otherwise noted. 1 Adj. Gross Margin and Adj. Diluted EPS are non-GAAP financial measures. Refer to the Appendix for reconciliations of non-GAAP financial measures to the most directly comparable financial measures calculated and presented in accordance with GAAP. 2 Diversified end markets, previously referred as the "non-transportation" market, includes the industrial, aerospace & defense, and medical end markets. 3 Refer to slide 2 for information on book-to-bill ratio. Q2 2025 – Driving Diversification and Profitability $135M Revenue +4% Second Quarter 38.7% Adj. Gross Margin1 +296 bps $0.57 Adj. Diluted EPS1 +7%

------

![Slide 4](cts-ex99_2s4.jpg)

Medical 4 Aerospace & Defense ($ Millions) Q2 YTD Revenue Q2 Sales $19M, up 8% year-over-year Book-to-bill ratio 1.0, compared to 1.1 in the second quarter of 2024 Added a new customer for medical ultrasound Received an award for a pacemaker application Q2 Sales $21M, up 34% year-over-year Bookings were flat year-over-year Received multiple orders for sonar transducers across North America and Europe, transducer refurbishments and outboard electronics ($ Millions) Q2 YTD Revenue End Markets Update

------

![Slide 5](cts-ex99_2s5.jpg)

Q2 sales $34M, up 6% year over year Bookings up 22% year over year Multiple wins for EMC, switches, industrial printing and temperature sensing applications Added a new customer for a small cell base station application Q2 sales $61M, down (6%) year over year – China and commercial vehicle softness ~$1B total booked business1 at end of Q2 2025 Multiple awards with customers in North America, Europe, and Asia End Markets Update Industrial 1 Refer to slide 2 for information on total booked business. 5 Transportation ($ Millions) Q2 YTD Revenue ($ Millions) Q2 YTD Revenue

------

![Slide 6](cts-ex99_2s6.jpg)

$2.35 $2.20 Notes: 1 Adjusted Diluted EPS is a non-GAAP financial measure. Refer to the Appendix for reconciliations of non-GAAP financial measures to the most directly comparable financial measures calculated and presented in accordance with GAAP. FY 2025 Guidance Revenue ($ Millions) Adjusted Diluted EPS 1 $520 $550 Continuation of current market conditions including: Monitoring the near-term economic impact of tariffs and the geopolitical environment, focusing on agility in adapting to cost and price adjustments. Continued progress on growth in diversified end markets Tax rate expected to be in the range of 19-21% excluding discrete items Key Outlook Assumptions

------

![Slide 7](cts-ex99_2s7.jpg)

2nd Quarter 2025 Financial Results

------

![Slide 8](cts-ex99_2s8.jpg)

Notes: All comparisons vs. same period in prior year unless otherwise noted. 1 Adj. Diluted EPS, Adj. Gross Margin and Adj. EBITDA Margin are non-GAAP financial measures. Refer to the Appendix for reconciliations of non-GAAP financial measures to the most directly comparable financial measures calculated and presented in accordance with GAAP. Diversified end market revenues up 13% vs. Q2 2024 SyQwest added $4.5M in revenue Transportation revenues down (6%) year over year –commercial vehicle and China softness Adjusted Gross Margin up 296 bps vs. Q2 2024 Minimal tariff impact in Q2 $1.0M favorable currency impact on gross margin Adjusted EBITDA up 132 bps vs. Q2 2024 Net Income $14.7 $13.4 $18.5 Diluted EPS $0.48 $0.44 $0.62 Adj. Diluted EPS1 $0.54 $0.44 $0.57 Adj. Gross Margin1 35.8% 37.0% 38.7% Adj. EBITDA Margin1 21.7% 20.5% 23.0% Revenue Q2 2025 Financial Summary Results ($ Millions, except percentages and per share amounts) Highlights

------

![Slide 9](cts-ex99_2s9.jpg)

$26M Cash Returned to Shareholders YTD 20253 Cash and Debt1 $36M Free Cash Flow YTD 20252 Strong Balance Sheet Solid Foundation for Strategic M&A $8M Capital Expenditures YTD 2025 Borrowed Total Facility Q2 YTD Operating Cash Flow Strong Cash Flow Generation ($ Millions) ($ Millions) Notes: 1 Cash and Debt balance as of June 30, 2025 2 Free Cash Flow is a non-GAAP financial measure. Refer to the Appendix for reconciliations of non-GAAP financial measures to the most directly comparable financial measures calculated and presented in accordance with GAAP. 3 Cash Returned to Shareholders consists of share repurchases and dividends.

------

![Slide 10](cts-ex99_2s10.jpg)

Q & A

------

![Slide 11](cts-ex99_2s11.jpg)

Appendix

------

![Slide 12](cts-ex99_2s12.jpg)

Non-GAAP Financial Measures From time to time, CTS may use non-GAAP financial measures in discussing CTS' business. These measures are intended to supplement, not replace, CTS' presentation of its financial results in accordance with U.S. GAAP. CTS believes that the non-GAAP financial measures presented are commonly used by financial analysts and others in the industries in which CTS operates, and thus further provide useful information to investors. CTS' definitions of these non-GAAP financial measures may differ from those terms as defined or used by other companies. Non-GAAP measures should not be used by investors or third parties as the sole basis for formulating investment decisions, as they may exclude a number of important cash and non-cash recurring items. CTS has presented these non-GAAP financial measures as it believes that the presentation of its financial results that exclude (1) restructuring charges; (2) restructuring-related charges; (3) environmental charges; (4) acquisition-related adjustments; (5) inventory fair value step-up costs; (6) foreign exchange (gains) losses; (7) non-cash pension expenses (income); and (8) certain discrete tax items are useful and assist in comparing CTS' current operating results with past periods and with the operational performance of other companies in its industry. Included below is a description of the expenses that CTS has determined are not normal, recurring cash operating expenses necessary to operate its business and the rationale for why providing financial measures for its business with such expenses excluded or adjusted is useful to investors as a supplement to the U.S. GAAP measures. Restructuring charges – costs primarily relating to workforce reductions, building and equipment relocations, asset impairment charges and other facility closure activities in connection with our continued optimization of our organization. Restructuring-related charges – costs related to restructuring actions that do not qualify as direct restructuring charges under U.S. GAAP. These include duplicative expenses arising from plant consolidation transition activities such as excess rent, utilities, personnel-related and other costs incurred prior to the start of production at a new location. Environmental charges – costs associated with our non-operating facilities that are unrelated to ongoing operations. Currently, none of these costs and accruals relate to sites that provide revenue generating activities for the Company. Acquisition-related adjustments – diligence and transaction costs related to acquisitions including related contingent earnout adjustments. Inventory fair value step-up costs – purchase accounting-related inventory costs from acquisitions. Foreign exchange (gains) losses – remeasurement income and expenses for non-U.S. subsidiaries with the U.S. dollar as the functional currency. Non-cash pension expenses (income) – pension income and expenses relating to the non-operating U.S. pension and post-retirement life insurance plans, including historical plan settlement activities. Discrete tax items – non-recurring, infrequent, or unusual tax adjustments (e.g., valuation allowances, uncertain tax position changes, unremitted assertion changes and discrete impacts associated with pre-tax non-GAAP items or due to tax law changes, etc.). At times, the reconciliations below have been intentionally rounded to the nearest thousand, or $0.01 for EPS figures, and, therefore, may not sum. CTS does not provide reconciliations of forward-looking non-GAAP financial measures, such as estimated adjusted diluted earnings per share, to the most comparable GAAP financial measures on a forward-looking basis because CTS is unable to provide a meaningful or accurate calculation or estimation of reconciling items and the information is not available without unreasonable effort. This is due to the inherent difficulty of forecasting the timing and amount of certain items, such as, but not limited to, restructuring costs, environmental remediation costs, acquisition-related costs, foreign exchange rates and other non-routine costs. Each of such adjustments has not yet occurred, are out of CTS' control and/or cannot be reasonably predicted. For the same reasons, CTS is unable to address the probable significance of the unavailable information. The Company updated certain previously furnished 2024 amounts due to immaterial errors identified. Refer to Note 1, "Basis of Presentation" in the Quarterly Report on Form 10-Q as of June 30, 2025 for more information.

------

![Slide 13](cts-ex99_2s13.jpg)

Regulation G Schedules ($ Millions, except percentages) Adjusted Gross Margin Three Months EndedJune 30, Six Months EndedJune 30, Three Months Ended March 31, LTM Twelve Months EndedDecember 31, 2025 2024 2025 2024 2025 Q3-24 to Q2-25 2024 2023 2022 2012 Gross margin $52.4 $46.4 $99.0 $91.5 $46.5 $195.0 $187.6 $190.9 $210.5 $91.5 Net sales $135.3 $130.2 $261.1 $255.9 $125.8 $520.0 $514.8 $550.4 $586.9 $304.5 Gross margin as a % of net sales 38.7% 35.6% 37.9% 35.7% 37.0% 37.5% 36.4% 34.7% 35.9% 30.1% Adjustments to reported gross margin: Restructuring-related charges (b) — 0.2 0.7 — — 0.7 0.6 — — Inventory fair value step-up (b) — — — — — 2.1 2.1 — 4.0 — Adjusted gross margin $52.4 $46.6 $99.0 $92.2 $46.5 $197.1 $190.4 $191.5 $214.5 $91.5 Adjusted gross margin as a % of net sales 38.7% 35.8% 37.9% 36.0% 37.0% 37.9% 37.0% 34.8% 36.5% 30.1%

------

![Slide 14](cts-ex99_2s14.jpg)

Regulation G Schedules ($ Millions, except percentages) Adjusted Operating Earnings Three Months EndedJune 30, Six Months EndedJune 30, LTM Twelve Months EndedDecember 31, 2025 2024 2025 2024 Q3-24 to Q2-25 2024 2023 2022 Operating earnings $22.7 $17.8 $39.0 $32.3 $67.4 $71.2 $75.1 $93.0 Net sales $135.3 $130.2 $261.1 $255.9 $520.0 $514.8 $550.4 $586.9 Operating earnings as a % of net sales 16.8% 13.6% 14.9% 12.6% 13.0% 13.8% 13.6% 15.8% Adjustments to reported operating earnings: Restructuring charges (c) 0.3 1.2 0.7 2.9 7.9 4.7 7.1 1.9 Restructuring-related charges (b) — 0.2 — 0.7 1.1 0.7 0.6 — Environmental charges (a) 0.2 0.5 0.4 0.7 3.2 1.6 3.5 2.8 Acquisition-related adjustments (a) (1.3) (0.3) (1.5) (0.6) (0.1) (0.3) 0.4 0.8 Inventory fair value step-up (b) — — — — — 2.1 — 4.0 Total adjustments to reported operating earnings $(0.8) $1.6 $(0.4) $3.8 $12.0 $8.8 $11.5 $9.5 Adjusted operating earnings $21.9 $19.4 $38.6 $36.1 $79.4 $80.0 $86.6 $102.5 Adjusted operating earnings as a % of net sales 16.2% 14.9% 14.8% 14.1% 15.3% 15.5% 15.7% 17.5%

------

![Slide 15](cts-ex99_2s15.jpg)

Regulation G Schedules ($ Millions, except percentages) Adjusted EBITDA Margin Three Months EndedJune 30, Six Months EndedJune 30, Three Months Ended March 31, LTM Twelve Months EndedDecember 31, 2025 2024 2025 2024 2025 Q3-24 to Q2-25 2024 2023 2022 Net earnings $18.5 $14.7 $31.9 $25.8 $13.4 $61.6 $55.5 $60.5 $59.6 Net sales $135.3 $130.2 $261.1 $255.9 $125.8 $519.9 $514.8 $550.4 $586.9 Net earnings margin 13.7% 11.3% 12.2% 10.1% 10.6% 11.8% 10.8% 11.0% 10.2% Depreciation and amortization expense 8.6 7.3 17.0 14.7 8.5 33.3 30.9 28.7 29.8 Interest expense 1.1 0.8 2.3 1.6 1.2 4.9 4.2 3.3 2.2 Tax expense 4.5 3.1 7.2 5.6 2.8 14.8 13.1 14.6 21.2 EBITDA 32.7 25.9 58.4 47.7 25.8 114.6 103.7 107.2 112.7 EBITDA Margin 24.2% 19.9% 22.4% 18.6% 20.5% 22.0% 20.1% 19.5% 19.2% Adjustments to EBITDA: Restructuring charges (c) 0.3 1.2 0.7 2.9 0.5 2.6 4.7 7.1 1.9 Restructuring-related charges (b) — 0.2 — 0.7 — — 0.7 0.6 — Environmental charges (a) 0.2 0.5 0.4 0.7 0.2 1.3 1.6 3.5 2.8 Acquisition-related adjustments (a) (1.3) (0.3) (1.5) (0.6) (0.2) (1.2) (0.3) 0.4 2.5 Inventory fair value step-up (b) — — — — — 2.1 2.1 — 4.0 Non-cash pension and related expense (d) — 0.1 0.1 0.1 — — 0.2 — 4.8 Foreign currency (gain) loss (d) (0.8) 0.6 (1.3) 2.1 (0.5) (0.8) 2.7 2.0 4.9 Total adjustments to EBITDA (1.6) 2.3 (1.6) 6.0 0.0 4.1 11.7 13.5 20.9 Adjusted EBITDA $31.1 $28.2 $56.8 $53.7 $25.8 $118.7 $115.4 $120.7 $133.6 Adjusted EBITDA Margin 23.0% 21.7% 21.8% 21.0% 20.5% 22.8% 22.4% 21.9% 22.8%

------

![Slide 16](cts-ex99_2s16.jpg)

Regulation G Schedules ($ Millions, except percentages and per share amounts) Adjusted Net Earnings and Adjusted Diluted Earnings Per Share Three Months EndedJune 30, Six Months EndedJune 30, Three Months Ended March 31, 2025 2025 2024 2024 2025 2025 2024 2024 2025 2025 Per Share Per Share Per share Per share Per share Net earnings (A) $18.5 $0.62 $14.7 $0.48 $31.9 $1.06 $25.8 $0.84 $13.4 $0.44 Adjustments to reported net earnings: Restructuring charges (c) 0.3 0.01 1.2 0.04 0.7 0.03 2.9 0.09 0.5 0.02 Restructuring related charges (a) — 0.00 0.2 0.01 — — 0.7 0.02 — — Environmental charges (a) 0.2 0.01 0.5 0.02 0.4 0.01 0.7 0.02 0.2 0.01 Acquisition-related adjustments (a) (1.3) (0.05) (0.3) (0.01) (1.5) (0.05) (0.6) (0.02) (0.2) (0.01) Non-cash pension and related expense (d) — — 0.1 — 0.1 — 0.1 — — — Foreign currency (gain) loss (d) (0.8) (0.03) 0.6 0.02 (1.3) (0.04) 2.1 0.07 (0.5) (0.01) Total pretax adjustments to reported net earnings $(1.6) $(0.06) $2.3 $0.07 $(1.6) $(0.05) $6.0 $0.19 $0.0 $0.01 Income tax effect of above adjustments (f) 0.3 0.01 (0.5) (0.02) 0.1 — (1.0) (0.03) (0.2) (0.01) Total adjustments, tax affected (f) (B) $(1.3) $(0.05) $1.8 $0.06 $(1.5) $(0.05) $5.0 $0.16 $(0.2) $— Tax adjustments: Other discrete tax items (e) 0.1 — — — 0.1 — 0.3 0.01 — — Total tax adjustments (C) $0.1 $— $— $— $0.1 $— $0.3 $0.01 $— $— Adjusted net earnings (A+B+C) and Adjusted net earnings per share $17.3 $0.57 $16.5 $0.54 $30.5 $1.01 $31.1 $1.01 $13.2 $0.44 Net sales $135.3 $130.2 $261.1 $255.9 $125.8 Net earnings as a % of net sales 13.7% 11.3% 12.2% 10.1% 10.6% Adjusted net earnings as a % of net sales 12.8% 12.7% 11.7% 12.1% 10.5%

------

![Slide 17](cts-ex99_2s17.jpg)

Regulation G Schedules ($ Millions, except percentages and per share amounts) Adjusted Net Earnings and Adjusted Diluted Earnings Per Share NOTE: CTS believes that adjusted gross margin, adjusted operating earnings, adjusted EBITDA margin, adjusted net earnings and adjusted diluted earnings per share provide useful information to investors regarding its operational performance because they enhance an investor's overall understanding of CTS' core financial performance and facilitate comparisons to historical results of operations, by excluding items that are not related directly to the underlying performance of CTS' fundamental business operations (such as those items noted above in the paragraph titled "Non-GAAP Financial Measures") or were not part of CTS' business operations during a comparable period. LTM Twelve Months EndedDecember 31, Q3-24 to Q2-25 2024 2024 2023 2023 2022 2022 2021 2021 2020 2020 Per share Per share Per share Per share Per share Per share Net earnings (loss) (A) $61.6 $2.03 $55.5 $1.80 $60.5 $1.92 $59.6 $1.85 $(41.9) $(1.30) $34.7 $1.06 Adjustments to reported net earnings (loss): Restructuring charges (c) 2.6 0.09 4.7 0.15 7.1 0.22 1.9 0.06 1.7 0.06 1.8 0.06 Restructuring related charges (a) — — 0.7 0.02 0.6 0.02 — — — — — — Environmental charges (a) 1.3 0.05 1.6 0.05 3.5 0.11 2.8 0.09 2.3 0.07 2.8 0.08 Acquisition-related adjustments (a) (1.2) (0.05) (0.3) (0.01) 0.4 0.01 2.5 0.08 — — 0.3 0.01 Inventory fair value step-up (b) 1.4 0.05 2.1 0.07 — — 4.0 0.12 — — — — Non-cash pension and related expense (d) 0.7 0.02 0.2 0.01 — — 4.8 0.15 132.4 4.10 0.6 0.08 Foreign currency loss (d) (0.7) (0.02) 2.7 0.09 2.0 0.06 4.9 0.15 3.3 0.10 (3.4) (0.16) Total pretax adjustments to reported net earnings (loss) $4.1 $0.14 $11.7 $0.38 $13.5 $0.42 $20.9 $0.65 $139.7 $4.33 $2.1 $0.07 Income tax effect of above adjustments (f) (1.2) (0.05) (2.2) (0.07) (2.4) (0.07) (1.6) (0.05) (31.1) (0.99) (1.7) (0.05) Total adjustments, tax affected (f) (B) $2.9 $0.09 $9.5 $0.31 $11.1 $0.35 $19.3 $0.60 $108.6 $3.34 $0.4 $0.02 Tax adjustments: Increase in valuation allowances (e) — — — — — — — — 0.9 0.03 0.2 — Other discrete tax items (e) 0.1 — 0.3 0.01 (1.6) (0.05) 0.2 0.01 (4.7) (0.14) 1.2 0.04 Total tax adjustments (C) $0.1 $— $0.3 $0.01 $(1.6) $(0.05) $0.2 $0.01 $(3.8) $(0.11) $1.4 $0.04 Adjusted net earnings (A+B+C) and Adjusted Net Earnings Per Share $64.6 $2.12 $65.3 $2.12 $70.0 $2.22 $79.1 $2.46 $63.0 $1.93 $36.5 $1.12 Net sales $520.0 $514.8 $550.4 $586.9 $512.9 $424.1 Net earnings (loss) as a % of net sales 11.8% 10.8% 11.0% 10.2% -8.2% 8.2% Adjusted net earnings as a % of net sales 12.4% 12.7% 12.7% 13.5% 12.3% 8.6%

------

![Slide 18](cts-ex99_2s18.jpg)

Reflected in selling, general and administrative and other (expense) income, net. Reflected in cost of goods sold. Reflected in restructuring charges. Reflected in other (expense) income, net. Reflected in income tax expense (income). For 2022, the discrete tax items relate to the net impact to tax expense of expired research and development credits, including the release of associated reserves. For 2023, discrete tax items include adjusting for tax benefits resulting from $0.6 million for research and development tax credits from prior years, $0.8 million in foreign tax credits related to prior years from a 2023 tax law change, as well as $0.2 million from the release of uncertain tax benefits. For 2024, the discrete tax items relate to items we deemed outside normal cash-generating operations including the addition of a valuation allowance for a foreign subsidiary. For 2025, the discrete tax items relate to items we deemed outside normal cash-generating operations including the addition of a valuation allowance for research and developmental credits and the tax impacts of an immaterial correction of a prior period error. We determine the tax effect of non-GAAP adjustments by considering the tax laws and statutory income tax rates applicable in the tax jurisdictions of the underlying non-GAAP adjustments. For all periods presented, we applied the statutory income tax rates to the taxable portion of all of our adjustments. Our acquisition costs and foreign currency gains and losses included in our non-GAAP adjustments were not deductible for income tax purposes; therefore, no statutory income tax rate was applied to such costs. Regulation G Schedules

------

![Slide 19](cts-ex99_2s19.jpg)

($ Millions, except percentages) Free Cash Flow ($ Millions, except percentages) Controllable Working Capital NOTE: CTS believes the controllable working capital ratio is a useful measure because it provides an objective measure of the efficiency with which CTS manages its short-term capital needs. NOTE: CTS believes that free cash flow is a useful measure because it demonstrates the company's ability to generate cash. Free cash flow is a non-GAAP measure and should be considered in addition to, but not as a substitute for, information contained in the company's condensed consolidated statement of cash flows as a measure of liquidity. Regulation G Schedules Three Months EndedJune 30, Twelve Months EndedDecember 31, 2025 2024 2024 2023 2022 Net accounts receivable $85.6 $85.4 $77.6 $78.6 $90.9 Net inventory $57.1 $51.7 $52.3 $60.0 $62.3 Accounts payable $(47.3) $(40.9) $(42.6) $(43.5) $(53.2) Controllable working capital $95.4 $96.2 $87.3 $95.1 $100.0 Quarter sales $135.3 $130.2 $126.4 $124.7 $142.3 Multiplied by 4 4 4 4 4 4 Annualized sales $541.2 $520.6 $505.6 $498.8 $569.1 Controllable working capital as a % of annualized sales 17.6% 18.5% 17.3% 19.1% 17.6% Three Months EndedJune 30, Six Months EndedJune 30, Twelve Months EndedDecember 31, 2025 2024 2025 2024 2024 2023 2022 Net cash provided by operating activities $28.4 $19.6 $43.9 $37.9 $98.2 $88.8 $121.2 Capital expenditures (3.3) (4.6) (7.7) (8.7) (18.6) (14.7) (14.3) Free cash flow $25.1 $15.0 $36.2 $29.3 $79.6 $74.1 $106.9 Operating cash flow as a percentage of net earnings 153% 133% 138% 147% 177% 147% 203% Operating cash flow as a percentage of adjusted EBITDA 91% 70% 77% 71% 85% 74% 91% Free cash flow as a percentage of adjusted net earnings 145% 91% 119% 94% 122% 106% 135%